摘要
目的:本研究的目的是分析重庆市中国老年人群阿尔茨海默病(AD)与骨质疏松症的风险之间的关系。 方法:2007年6月至2013年1月间对60- 75岁的1802例患者进行了6年的随访的前瞻性研究。用双能X线骨密度仪来评估骨密度(BMD)。采用简易精神状态检查量表(MMSE)中文版和日常生活活动(ADL)的检测工具检测认知功能。Cox比例风险模型被用于检测AD和骨质疏松的风险之间的关联。 结果:调整了年龄、女性、AD,25-羟基维生素D(25(OH)D)、吸烟、饮酒与中风,AD(风险比,HR 2.48,95% CI 1.66-2.94)、年龄(HR 1.36,95% CI 1.14-1.60)、女性(HR 1.39,95% CI 1.17-1.65)、25(OH)D(HR 1.34,95% CI 1.11-1.59)、目前吸烟(HR 1.27,95% CI 1.22-1.43),每天饮酒(HR 1.33,95% CI 1.11-1.52)和中风(HR 1.26,95% CI 1.14-1.58)与骨质疏松症的风险增加有关。在骨质疏松性骨折组中,AD的骨质疏松症比认知功能的正常的骨质疏松症更常见。 结论:中国重庆老年人群AD与骨质疏松症的风险增加有关。
关键词: 阿尔茨海默病,痴呆症,雌激素,骨折,高胆固醇血症,骨质疏松症。
Current Alzheimer Research
Title:Alzheimer’s Disease is Associated with Increased Risk of Osteoporosis: The Chongqing Aging Study
Volume: 13 Issue: 10
Author(s): Dong Liu, Huadong Zhou, Yong Tao, Jun Tan, Lin Chen, Haiyang Huang, Yang Chen, Yafei Li, Rui Zhou
Affiliation:
关键词: 阿尔茨海默病,痴呆症,雌激素,骨折,高胆固醇血症,骨质疏松症。
摘要: Objective: The aim of this study was to analyze the relationship between Alzheimer’s disease (AD) and a risk of osteoporosis in the elderly cohort of Chongqing, China.
Methods: A prospective study with 6 years of follow-up in 1802 patients aged 60– 75 was conducted from January 2007 to June 2013. Dual energy X-ray absorptiometry was utilized to evaluate bone mineral density (BMD). Their cognitive function was detected using the Chinese version of the Mini-Mental State Examination (MMSE) and a detection of the instrumental activities of daily living (ADL). Cox proportional hazards models were used to detect the association between AD and the risk of osteoporosis.
Results: After adjusting for age, female, AD, 25-hydroxyvitamine D (25(OH)D), smoking, drinking and stroke, AD (Hazard ratio, HR 2.48, 95%CI 1.66-2.94), age (HR 1.36, 95% CI 1.14-1.60), female (HR 1.39, 95% CI 1.17-1.65), 25(OH)D (HR1.34, 95%CI 1.11-1.59), current smoking (HR 1.27, 95%CI 1.22-1.43), daily drinking (HR 1.33, 95%CI 1.11-1.52) and stroke (HR 1.26, 95%CI 1.14-1.58) were associated with increased risk of osteoporosis. In osteoporosis fracture group, osteoporosis with AD was more common than osteoporosis with normal cognition function.
Conclusion: AD was associated with an increased risk of osteoporosis in the elderly cohort of Chongqing, China.
Export Options
About this article
Cite this article as:
Dong Liu, Huadong Zhou, Yong Tao, Jun Tan, Lin Chen, Haiyang Huang, Yang Chen, Yafei Li, Rui Zhou , Alzheimer’s Disease is Associated with Increased Risk of Osteoporosis: The Chongqing Aging Study, Current Alzheimer Research 2016; 13 (10) . https://dx.doi.org/10.2174/15672050113109990149
DOI https://dx.doi.org/10.2174/15672050113109990149 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease
Current Topics in Medicinal Chemistry Cardiovascular Molecular Imaging: New Methodological Strategies
Current Pharmaceutical Design ATP Binding Cassette Transporter A1 (ABCA1) Associated Proteins:Potential Drug Targets in the Metabolic Syndrome and Atherosclerotic Disease?
Current Pharmaceutical Biotechnology Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology Predicting Drug Metabolism Induction In Silico
Current Topics in Medicinal Chemistry Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy
Current Pharmaceutical Design A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Mini-Reviews in Medicinal Chemistry The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade
Current Clinical Pharmacology Actions of Selected Cardiovascular Hormones on Arterial Stiffness and Wave Reflections
Current Pharmaceutical Design Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Lipases as Modulators of Atherosclerosis in Murine Models
Current Drug Targets Essential Oils with Microbicidal and Antibiofilm Activity
Current Pharmaceutical Biotechnology Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience
Current Alzheimer Research Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Atypical Neurotransmitters and the Neurobiology of Depression
CNS & Neurological Disorders - Drug Targets Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans
Letters in Drug Design & Discovery The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued)